trending Market Intelligence /marketintelligence/en/news-insights/trending/HfzW7do-bIYIS3vXUR7P9w2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Sweden's Elekta gains US FDA approval for diffusion-weighted images

Blog

Needham & Company is Now Available in the S&P Global Market Intelligence Aftermarket Research Collection

Blog

Banking Essentials Newsletter - February Edition

Blog

Message in a (Word)Cloud

Six trends shaping the industries and sectors we cover in 2021


Sweden's Elekta gains US FDA approval for diffusion-weighted images

Elekta AB (publ) said the U.S. Food and Drug Administration approved the use of Elekta Unity in diffusion-weighted imaging.

The FDA clearance allows diffusion-weighted images derived using Elekta Unity to be interpreted by trained physicians.

Diffusion-weighted imaging is a technique that uses the motion of water molecules to create contrast in magnetic resonance images.

The Stockholm-based company's Elekta Unity technology allows doctors to better target cancers and allows for personalized radiation therapy regimens.